Which adverse effects would you monitor closely for in a patient taking atomoxetine?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Which adverse effects would you monitor closely for in a patient taking atomoxetine?

Explanation:
Atomoxetine carries a notable safety warning for suicidality, especially in children and adolescents, so the primary reason to monitor is the emergence or worsening of suicidal thoughts or actions after starting treatment or adjusting the dose. Patients should be regularly checked for mood changes, sudden agitation, insomnia, or self-harm thoughts, and caregivers should be involved in ongoing monitoring. If such symptoms appear, a clinician should re-evaluate the treatment plan promptly. Other listed effects like headaches or weight changes can occur, but they don’t carry the same urgent safety signal as suicidality, and a rash is an uncommon concern.

Atomoxetine carries a notable safety warning for suicidality, especially in children and adolescents, so the primary reason to monitor is the emergence or worsening of suicidal thoughts or actions after starting treatment or adjusting the dose. Patients should be regularly checked for mood changes, sudden agitation, insomnia, or self-harm thoughts, and caregivers should be involved in ongoing monitoring. If such symptoms appear, a clinician should re-evaluate the treatment plan promptly. Other listed effects like headaches or weight changes can occur, but they don’t carry the same urgent safety signal as suicidality, and a rash is an uncommon concern.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy